Keywords: Inflammation; Leukocyte; Non-communicable diseases; Receptor; Renin-angiotensin system; ABI; ankle-brachial index; ACE; angiotensin-converting enzyme; ATRAP; angiotensin II type 1 receptor-associated protein; AT1R; angiotensin II type 1 receptor; BM-KO; b
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AA; amino acid; Fc; ferrocene; MB; methylene blue; AMP; antimicrobial peptide; CPP; cell-penetrating peptide; Aib; α-aminoisobutyric acid; SAM; self-assembled monolayers; ADNT; aromatic dipeptide nanotubes; ET; electron transfer; CV; cyclic voltammetry;
Keywords: Obesity; Glomerular filtration rate; Indexing; Scaling; eGFR;
Keywords: ABC; ATP-binding cassette; ASBT; apical sodium-dependent bile acid transporter; Bamet-UD2; cisplatin-ursodeoxycholic acid derivative; CCA; cholangiocarcinoma; DHMEQ; dehydroxymethyl epoxyquinomicin; EGFR; epidermal growth factor receptor; 5-FU; 5-fluorour
Keywords: FASN; EGFR; Nicotine; Oral premalignant lesions; Oral cancer; Cell migration;
Keywords: MW; molecular weight; MDR1; multiple drug resistance 1; P-gp; P-glycoprotein; ABC-transporter; ATP-binding cassette transporter; ATP; adenosine triphosphate; BBB; blood brain barrier; SLC transporter; solute carrier transporter; logP; partition coefficien
Keywords: BB; bevacizumab-bevacizumab; BP; bevacizumab followed by panitumumab; CA9; carbonic anhydrase 9; CRC; colorectal cancer; DEGs; differentially expressed genes; EGFR; epidermal growth factor receptor; EPHA2; ephrin type-A receptor 2; FASN; fatty acid syntha
Keywords: PD-1; programed cell death-1; PD-L1; programmed cell death ligand 1; NSCLC; non-small-cell lung cancer; OS; overall survival; PFS; progression-free survival; ORR; objective response rate; irAEs; immune-related adverse events; RECIST; response evaluation c
Keywords: BMI; body mass index; eGFR; estimated glomerular filtration rate; ESRD; end-stage renal disease; HBO; hyperbaric oxygen; HR; hazard ratio; IL; intralesional; IQR; interquartile range; IV; intravenous; MGH; Massachusetts General Hospital; NNC; nonnephrogen
Keywords: Small molecules; biologics; adverse effects mouth; BP; Bisphosphonates; EGFR; Epidermal growth factor receptor; FDA; Food and Drug Administration; HER2; Human epidermal growth factor receptor 2; HNSCC; Head and neck squamous cell carcinoma; mAbs; Monoclon
Keywords: AKI; acute kidney injury; BMI; body mass index; CHF; congestive heart failure; CMS; Centers for Medicare & Medicaid Services; COPD; chronic obstructive pulmonary disease; CV; cardiovascular; eGFR; estimated glomerular filtration rate; ESRD; end-stage rena
Keywords: ACEI; angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; DM; diabetes mellitus; eGFR; estimated glomerular filtration rate; EHR; electronic health record; ESRD; end-stage renal disease; FSGS; focal segmental glomerulosclerosis; GN
Keywords: α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
Keywords: Fabry disease; Diagnosis; Mutation; Management; Treatment; ACEI; angiotensin converting enzyme inhibitor; ARB; angiotensin receptor blocker; AV; atrioventricular; α-Gal A; α-galactosidase A; CKD; chronic kidney disease; CNS; central nervous system; CT;
Keywords: 2hPPPG; post-prandial plasma glucose; ANOVA; analysis of variance; AUC; area under the curve; CKD; chronic kidney disease; Creat; serum creatinine; DBP; diastolic Blood Pressure; DN; diabetic nephropathy; DM; diabetes mellitus; eGFR; estimated glomerular
Keywords: CMS; Centers for Medicare and Medicaid Services; eGFR; estimated glomerular filtration rate; ESRD; end-stage renal disease; ICD-9-CM; International Classification of Diseases; Ninth Revision; Clinical Modification; IQR; interquartile range; KPSC; Kaiser P
Keywords: NPs; nanoparticles; siRNA; small interfering RNA; miRNA; microRNA; DC-Chol; 3b(N-(N¢,N¢-dimethylaminoethane)carbarmoyl)-cholesterol; DOPE; dioleoylphosphatidylethnolamine; DMRIE; 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide; DOTAP; 1
Keywords: ACEI; angiotensin-converting enzyme inhibitor; aHR; adjusted hazard ratio; ARB; angiotensin receptor blocker; BMI; body mass index; CHF; congestive heart failure; CKD; chronic kidney disease; eGFR; estimated glomerular filtration rate; ESRD; end-stage ren
Keywords: T2DM; type 2 diabetes; T1DM; type 1 diabetes; GPMSSP; General Practitioners' Morbidity Sentinel Stations Program; OR; odds ratio; 95%CI; 95% confidence interval; EUBIROD; EUropean Best Information through Regional Outcomes in Diabetes; NIHIFM; National
Keywords: 5-fluorouracil; imiquimod; ingenol mebutate; acitretin; American Joint Commission on Cancer; Brigham and Women's Hospital staging system; capecitabine; CDKN2A; cetuximab; chemotherapy; classification; cSCC; CT; cutaneous squamous cell carcinoma; familial
Keywords: BALB 3T3; mouse embryonic fibroblast cells; Bn; bombesin; BnR; bombesin receptors; BRS-3; bombesin receptor subtype-3; BSA; bovine serum albumin fraction V; CNS; central nervous system; DMEM; Dulbecco's minimum essential medium; EGFR; epidermal growth f
Keywords: NSCLC; Non-Small Cell Lung Carcinoma; SCLC; Small Cell Lung Carcinoma; AC; Adenocarcinoma; LCT; Lung Carcinoid Tumor; LCC; Large Cell Carcinoma; CTC; Circulating Tumor Cells; UICC; The Union for International Cancer Control; CT; Computer-based Tomography;
Keywords: Ovarian cancer; EGFR; HER-2; c-MET; 3D cell culture; Targeted inhibitors; Ascites;
Keywords: 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: Preoperative Therapy; Immune Checkpoint Inhibitors; HER2 Targeted Therapy; VEGF Targeted Therapy; ECF; epirubicin, cisplatin, and 5-FU; EGFR; epidermal growth factor receptor; FLOT; 5-FU and oxaliplatin; 5-FU; 5-fluorouracil; GEJ; gastroesophageal junctio
Keywords: lung disease; regenerative medicine; stem cells; AECII; type II alveolar epithelial cell; ALI; air-liquid interface; BASC; bronchioalveolar stem cell; BC; basal cell; CC; club cell; EGFR; epidermal growth factor receptor; FZD4; Frizzled; IPF; idiopathic p
Keywords: ALK; Anaplastic Lymphoma Kinase; CI; Confidence interval; CT; Computerized Tomography; EGFR; Epidermal Growth Factor Receptor; ESMO; European Society of Medical Oncology; 18F-FDG; Fluorodeoxyglucose; IQR; Interquartile range; MATV; Metabolic Active Tumor
Keywords: AAV; adeno-associated viruses; ADA; adenosine deaminase deficiency; APCs; antigen presenting cells; AuNC; gold nanoclusters; AuNPs; gold nanoparticles; AuNRs; gold nanorods; BBB; blood-brain barrier; Bcl-2; B-cell lymphoma 2; Cas; CRISPR-associated; ChNPs
Keywords: Coffee consumption; Metabolic syndrome; Type 1 diabetes; Insulin resistance; Renal function; eGDR; estimated glomerular disposal rate; eGFR; estimated glomerular filtration rate; hsCRP; high-sensitivity C-reactive protein; MS; metabolic syndrome; T1D; typ
Keywords: FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: CKD; Chronic kidney disease; TG; Triglyceride; AOR; Adjusted odds ratio; COR; Crude odds ratio; MDRD-4; Modification of diet in renal disease 4 variables; HbA1c; Glycated haemoglobin; LDL-C; Low density lipoprotein cholesterol; WHO; World Health Organizat
Keywords: Pulmonary adenocarcinoma; Caucasian; EGFR; TP53; KRAS; STK11;
Keywords: BMP; bone morphogenetic protein; cMRI; cardiac magnetic resonance imaging; CSC; cardiac stem/progenitor cell; CABG; coronary artery bypass graft; CAD; coronary artery disease; Cnx43; connexin-43; CTnI; cardiac troponin I; DKK 1; dickkopf-related protein 1
Keywords: ACE-I; angiotensin-converting-enzyme inhibitors; ALP; alkaline phosphatase; ARBs; angiotensin 2 receptor blockers; BMI; body mass index; CKD-EPI; chronic kidney disease epidemiology collaboration; CVD; cardiovascular disease; ESRD; end stage renal disease
Keywords: AKI; acute kidney injury; CHF; congestive heart failure; CI; confidence interval; CKD; chronic kidney disease; eGFR; estimated glomerular filtration rate; EuroSCORE; European System for Cardiac Operative Risk Evaluation; HR; hazard ratio; MI; myocardial i
Keywords: α-SMA; α-smooth muscle actin; AIF; apoptosis inducing factor; AP-1; activator protein 1; ARE; antioxidant response element; Bax; Bcl-2 associated X protein; Bcl-2; B-cell lymphoma 2; Bcl-xl; B cell lymphoma extra large; CDKCs; cyclin:CDK complexes; c-My
Keywords: Immunoassay; Serum biomarker; Cancer; Follow-up; Prognosis; Histotype; HE4; human epididymis protein 4; OC; ovarian cancer; CA125; carbohydrate antigen 125; HR; hazard ratio; PFS; progression-free survival; NCCN; National Comprehensive Cancer Network; GCI
Keywords: ABC; ATP-binding cassette; BCRP; breast cancer protein; EGFR; epidermal growth factor receptor; MDR; multidrug resistance; Drug resistance; Oncogene; Medicinal plants; Pharmacognosy; Tumor suppressor;
Keywords: AF; atrial fibrillation; AOC_MAC; aortic calcium - mitral annulus calcium; CAC; coronary artery calcium; CAD; coronary artery disease; CCV; Cardiovascular Centre; CHD; coronary heart disease; CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration; CKD
Keywords: NSCLC; non-small cell lung cancer; EGFR; epidermal growth factor receptor; OR; odds ratio; HR; hazards ratio; CI; confidence interval; ALK; anaplastic lymphoma kinase; OS; overall survival; NHIS; National Health Insurance Service; NHID; National Health In
Keywords: AAPC; Average Annual Percent Change; ALK; anaplastic large-cell lymphoma kinase; ANVISA; Brazilian Health Surveillance Authorities; APC; annual percent change; EGFR; epidermal growth factor receptor mutations; FOSP; São Paulo Cancer Foundation; IBGE; Bra
Keywords: Sporadic/hereditary pituitary tumors; Whole genome/exome sequencing; USP8 mutation; Pituitary adenoma progression; Pituitary carcinoma; Pituitary tumor senescence; AIP; aryl hydrocarbon-interacting protein; BC; bromocriptine; bFGF; basic fibroblast growth
Keywords: CT; computed tomography; C/T; consolidation/tumor ratio; EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; OS; overall survival; pD-L1; programmed cell death-1 ligand; PET; positron emission tomography; RFS; recurrence-free surviv
Keywords: Trajectory; Adverse renal event; eGFR; ACR; Diabetic patients;
Keywords: Diabetic kidney disease; eGFR; Albuminuria; Cardiovascular disease; Mortality;
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: Erlotinib; Fulvestrant; Lung cancer; EGFR; Estrogen; Estrogen receptor;
Keywords: Beads; Sensors; Biosensors; Analytical chemistry; Analyte; AIDS; acquired immune deficiency syndrome; ALP; alkaline phosphatase; BSA; bovine serum albumin; CSDPV; cathodic stripping differential pulse voltammetry; DNA; deoxyribonucleic acid; DPV; differen
Keywords: ABCB1; ATP-binding cassette sub-family B member 1; ABCG; ATP-binding cassette drug efflux transporters; ACD; autophagic cell death; AKT; alpha serine/threonine protein kinase; ALDH; aldehyde dehydrogenase; AMPK; AMP-activated protein kinase; AP; apurinic/
Keywords: EGFR; TP53; KRAS, non-small-cell lung cancer; Prognostic;